Lipidor: First Patient In for Phase III trials of new high- comfort, high-control anti-psoriasis spray 5 October 2018
PKU GOLIKE debuts at SSIEM 2018 Conference: science driven innovation behind the medical food for PKU management of APR Applied Pharma Research 13 September 2018
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI® (palonosetron HCl) 16 August 2018
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S. 2 July 2018
Helsinn Group and Angelini support Satellite Symposium at MASCC/ISOO 2018 Annual Meeting 26 June 2018
Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center 5 June 2018
Linkedin